Skip to main content
    S

    Surrozen Inc (SRZN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $32.32
    +0.71 (+2.25%)

    Market Cap: $602.54M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Surrozen Inc (SRZN) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Surrozen (SRZN) to earn -$18.78 per share in the fiscal year ending Dec 31, 2026, on revenue of $10.20M. Of 6 analysts, 6 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$4.71.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy6100.0%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    6

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates fall 92.2%.

    Fiscal year ending Dec 31, 2026
    -$18.78
    EPS consensus, revenue $10.20M
    Fiscal year ending Dec 31, 2027
    -$4.71
    EPS consensus, revenue $800000

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$18.78-$18.78 to -$18.781$10.20M$10.00M to $11.00M5
    Dec 31, 2027-$4.71-$5.19 to -$3.933$800000N/A5

    Quarterly Estimates

    The EPS consensus falls from -$0.95 for the quarter ending Dec 31, 2026 to -$1.00 for the quarter ending Mar 31, 2027.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.95-$1.28 to -$0.648$484500N/A6
    Mar 31, 2027-$1.00-$1.03 to -$0.972$500000N/A2

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Fiscal year ending Dec 31, 202702
    Quarter ending Mar 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$9.14.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$18.78-$9.14-$9.14-$9.14-$9.14N/A
    Fiscal year ending Dec 31, 2027-$4.71-$4.19-$4.19-$4.19-$4.58N/A
    Quarter ending Mar 31, 2027-$1.00-$0.87-$0.87-$0.87-$0.86N/A

    Frequently Asked Questions About SRZN

    What is the SRZN stock forecast?

    Consensus analyst estimates put Surrozen's EPS at -$18.78 for the fiscal year ending Dec 31, 2026, on revenue of $10.20M. The consensus rating from 6 analysts is Buy.

    How do analysts rate SRZN stock?

    Of 6 analysts covering Surrozen, 0 rate it Strong Buy, 6 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from SRZN next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$18.78, with estimates from -$18.78 to -$18.78 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$4.71, with estimates from -$5.19 to -$3.93 from 3 analysts.

    What revenue do analysts expect from Surrozen next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $10.20M, with estimates from $10.00M to $11.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $800000.

    How many analysts cover SRZN?

    6 analysts rate Surrozen stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.